Nama Insights

VanEck Pharmaceutical ETF (PPH)

Health · VanEck · NASDAQ

HealthETF
VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund in the Health category. It has $879.46M in assets, an expense ratio of 0.36% and a 1.97% dividend yield. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Assets under management$879.46M
Expense ratio0.36%
CategoryHealth
Dividend yield1.97%
NAV$110.35
Fund familyVanEck
ExchangeNASDAQ

Top holdings

The largest positions VanEck Pharmaceutical ETF reports, by weight.

HoldingNameWeight
LLY Eli Lilly and Co 20.62%
NVS Novartis AG ADR 10.62%
MRK Merck & Co Inc 9.85%
NVO Novo Nordisk AS ADR 5.38%
ABBV AbbVie Inc 4.60%
PFE Pfizer Inc 4.53%
BMY Bristol-Myers Squibb Co 4.51%
GSK GSK PLC ADR 4.42%
JNJ Johnson & Johnson 4.41%
AZN.L AstraZeneca PLC 4.34%

Other Health ETFs

Explore live PPH data on Nama Insights →